142 related articles for article (PubMed ID: 8491239)
1. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.
Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB
Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239
[TBL] [Abstract][Full Text] [Related]
2. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil.
McGready R; Stepniewska K; Seaton E; Cho T; Cho D; Ginsberg A; Edstein MD; Ashley E; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2003 Oct; 59(7):553-7. PubMed ID: 12955370
[TBL] [Abstract][Full Text] [Related]
4. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
[TBL] [Abstract][Full Text] [Related]
6. The multiple dose pharmacokinetics of proguanil.
Helsby NA; Edwards G; Breckenridge AM; Ward SA
Br J Clin Pharmacol; 1993 Jun; 35(6):653-6. PubMed ID: 8329294
[TBL] [Abstract][Full Text] [Related]
7. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults.
Watkins WM; Mberu EK; Nevill CG; Ward SA; Breckenridge AM; Koech DK
Trans R Soc Trop Med Hyg; 1990; 84(4):492-5. PubMed ID: 2091335
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.
Sabchareon A; Attanath P; Phanuaksook P; Chanthavanich P; Poonpanich Y; Mookmanee D; Chongsuphajaisiddhi T; Sadler BM; Hussein Z; Canfield CJ; Hutchinson DB
Trans R Soc Trop Med Hyg; 1998; 92(2):201-6. PubMed ID: 9764334
[TBL] [Abstract][Full Text] [Related]
10. Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride.
Jamaludin A; Mohamad M; Navaratnam V; Yeoh PY; Wernsdorfer WH
Trop Med Parasitol; 1990 Sep; 41(3):268-72. PubMed ID: 2255843
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.
Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T
Br J Clin Pharmacol; 1995 Mar; 39(3):297-303. PubMed ID: 7619672
[TBL] [Abstract][Full Text] [Related]
12. Human pharmacokinetics of proguanil and its metabolites.
Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
[TBL] [Abstract][Full Text] [Related]
13. Lack of a pharmacokinetic interaction between atovaquone and proguanil.
Gillotin C; Mamet JP; Veronese L
Eur J Clin Pharmacol; 1999 Jun; 55(4):311-5. PubMed ID: 10424325
[TBL] [Abstract][Full Text] [Related]
14. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
Edstein MD; Veenendaal JR; Rieckmann KH
Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status.
Kusaka M; Setiabudy R; Chiba K; Ishizaki T
Am J Trop Med Hyg; 1996 Feb; 54(2):189-96. PubMed ID: 8619446
[TBL] [Abstract][Full Text] [Related]
16. Determination of proguanil and metabolites in small sample volumes of whole blood stored on filter paper by high-performance liquid chromatography.
Kolawole JA; Taylor RB; Moody RR
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):149-54. PubMed ID: 8749264
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
Helsby NA; Ward SA; Edwards G; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1990 Oct; 30(4):593-8. PubMed ID: 2291871
[TBL] [Abstract][Full Text] [Related]
18. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz.
Soyinka JO; Onyeji CO
Eur J Pharm Sci; 2010 Feb; 39(4):213-8. PubMed ID: 19961932
[TBL] [Abstract][Full Text] [Related]
19. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatography of proguanil, cycloguanil and 4-chlorophenylbiguanide using hydrophobic pairing ion and its application to serum assay.
Moody RR; Selkirk AB; Taylor RB
J Chromatogr; 1980 Jun; 182(3-4):359-67. PubMed ID: 7391178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]